新規ヒスタミンH_2受容体拮抗薬, キュバン誘導体(SWR-104SA)の酸分泌及び実験的潰瘍形成に対する作用

スポンサーリンク

概要

• 論文の詳細を見る

• The antagonism of histamine H_2-receptor by SWR-104SA (1'-bromo-N-[3-[3-(1-piperidinylmethyl) phenoxy] propyl]-spiro [1,3-dioxolane-2,9'-pentacyclo-[4. 3. 0. 0.^<2,5>0.^<3,8>0.^<4,7>] nonane]-4'-carboxamide monooxalate) was estimated using the isolated guinea-pig atrium and gastric acid secretion in rats. The concentration-response curves for the positive chronotropic effect of histamine on the atrium were displaced to the right in parallel without change in the maximum response by SWR-104SA and roxatidine acetate hydrochloride (roxatidine). The pA_2 values of SWA-104SA and roxatidine acetate hydrochloride were 7.27 and 7.38,respectively. The slopes of the regression line of log (DR-1) against log SWR-104SA and roxatidine concentration were 1.00 and 0.92,respectively. There was no significant difference between the two compounds with respect to the histamine H_2-receptor antagonism and/or binding manner in vitro. In the rat gastric fistula model stimulated by histamine, however, antisecretory potency of SWR-104SA was 3 times less than that of roxatidine. SWR-104SA given p.o. prevented the formation of gastric lesion induced by HCl-ethanol and indomethacin dose-dependently, roxatidine also prevented its formation by HCl-ethanol, but failed to prevent that by indomethacine. These antiulcer activities of SWR-104SA were shown at the lesser doses of antisecretory activity. On the other hand, roxatidine did not prevent the ulcer formation at the same dose level of antisecretory activity. These results indicate that the antiulcer effect of SWR-104SA is not caused by the antisecretory action alone. In addition, the mucosal protective activity of SWR-104SA for HCl-ethanol induced gastric lesion was independent of endogenous prostaglandins. Moreover SWR-104SA had inhibitory effects on indomethacin-induced gastric hypermotility in rats. These actions may partly explain the gastric protection of this compound and additional mechanisms such as mucosal blood flow could be involved in the antiulcer efficacy. Consequently, it appears that SWR-104SA is a new antiulcer drug that exerts a potent cytoprotective effect in addition to its gastric antisecretory activity.

• 公益社団法人日本薬学会の論文
• 1996-10-25

著者

• 木曽 達也

  沢井製薬

• 新川 蘭順

  沢井製薬株式会社 研究部

• 木曽 達也

  沢井製薬株式会社 研究部

• 片岡 博文

  沢井製薬株式会社 研究部

• 礒井 孝

  沢井製薬株式会社 研究部

• 柿田 孝雄

  沢井製薬株式会社 研究部

• 正垣 武志

  沢井製薬株式会社 研究部

• 大坪 義和

  沢井製薬株式会社 研究部

• 片岡 博文

  沢井製薬株式会社 生物研究部

• 正垣 武志

  Research Department Sawai Pharmaceutical Co. Ltd.

• 大坪 義和

  沢井製薬株式会社生物研究部

• 大坪 義和

  沢井製薬

関連論文

• ラタノプロスト点眼液0.005%「サワイ」の角結膜障害性の評価
• 57(P17) 質量分析法による食用キノコに含まれる苦味物質前駆体,新規ポリイソプレンポリオールの構造解析(ポスター発表の部)
• 新規ヒスタミンH_2受容体拮抗薬, キュバン誘導体(SWR-104SA)の酸分泌及び実験的潰瘍形成に対する作用
• 1,6-Asymmetric Induction by Reductive Acetal Cleavage of a Bicyclic Acetal Using a Sulfinyl Chiral Auxiliary
• ICR系雌性マウスにおける自発行動量, 摂餌量, 摂水量, 体重, 器官重量, 血糖値, および血中コレステロール値に対する各種床敷材の影響
• Anti-obesity and Anti-diabetic Activities of a New β_3 Adrenergic Receptor Agonist, (S)-(Z)-[4-[[1-[2-[(2-Hydroxy-3-phenoxypropyl)]amino]athyl]-1-propenyl]phenoxy] Acetic Acid Ethanedioic Acid (SWR-0342SA), in KK-A^y Mice
• 1,6-Asymmetric Induction Utilizing Asymmetric Desymmetrization by Diastereoselective C-O Bond Fission of the 4-Substituted Bicyclic Acetal : Application to a Synthesis of (-)-Frontalin
• Pharmacological Profiles of a New Antiulcer Agent, SWR-215
• Studies on Protopectinase-C Mode of Action : Analysis of the Chemical Structure of the Specific Substrate in Sugar Beet Protopectin and Characterization of the Enzyme Activity
• ラタノプロスト点眼液0.005%「サワイ」の角結膜障害性の評価

スポンサーリンク